Teva Pharmaceuticals Agrees to Pay Rhode Island $21M, Provide Opioid Treatment Options - MarketWatch
Teva Stock Climbs as CEO Says Opioid Settlement Could Come Within a Year | Barron's
Hedge Funds Are Dipping Their Toes Into Teva Pharmaceutical Industries (TEVA )
Is the new Teva x Ugg collection fashion-forward or just plain ugly? - MarketWatch
Israel stocks at record; Biogen remarks cost Teva - MarketWatch
Israel stocks up, led by Teva, Bezeq - MarketWatch
Is Teva Pharmaceutical (TEVA) a Good Stock to Pick Now?
Is Teva Pharmaceutical (TEVA) a Good Stock to Pick Now?
What To Do After TEVA Stock Falls Below $10 Again (NYSE:TEVA) | Seeking Alpha
Trump makes the case for chloroquine as a COVID-19 treatment, though it has not been approved by the FDA for this illness - MarketWatch
Mylan and Teva stocks rise on report about Amazon's pharmacy aims - MarketWatch
Is Teva Pharmaceutical (TEVA) a Good Stock to Pick Now?
Israel stocks fall for fifth day; Teva rises - MarketWatch
Teva beats first-quarter expectations but still has the same old problems - MarketWatch
Is TEVA Stock A Buy or Sell?
Is Teva Pharmaceutical (TEVA) a Good Stock to Pick Now?
Teva stock drops 10% as generics turnaround looks uncertain - MarketWatch
Israel stocks tick lower; Teva, Itamar in focus - MarketWatch
Teva Suffers Loss In New York's Opioid Trial
Is Teva Pharmaceutical (TEVA) a Good Stock to Pick Now?
Teva releases generic version of Mylan's EpiPen in limited doses in the U.S. - MarketWatch
Three health-care deals today are paying huge premiums - MarketWatch
Passive meets aggressive in Teva-Mylan talks - MarketWatch
Shares of generic drugmakers rise on hope that legal issues are nearing an end - MarketWatch
